您使用提示模式 关闭

HLTH - VanEck Vectors Global Healthcare Leaders ETF (AU0000102683)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
AU0000102683
HLTH ISIN
交易所交易基金 (ETF)
基金类型
VanEck
提供商
11,59 AUD
每股资产净值 | 2026-07-10
2020-09-08
成立日期
1 每年的次数
股息的支付
CEXXXU
CFI
HLTH
代码
Formed
Status
Equity
投资项目
Healthcare
部门
Developed markets
地区分布
MarketGrader Developed Markets (ex-Australia) Health Care Index 
基准
0.45 %
总成本比率
51,66 百万 AUD
基金资产总量 | 2026-07-10
51,66 百万 AUD
股票类资产 | 2026-07-10
否
UCITS

收益率 在 2026-07-13, Australian S.E.

  • YTD
    -10,9 %
  • 1M
    -3,57 %
  • 3M
    -8,95 %
  • 6M
    -13,4 %
  • 1Y
    -4,26 %
  • 3Y
    4,5 %
  • 5Y
    6,6 %
  • 10Y
    -
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (HLTH)

探索最全面的数据库

1 000 000

债券

80 234

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

HLTH profile

The VanEck Vectors Global Healthcare Leaders ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Developed markets. The VanEck fund’s base currency is AUD and the share class was registered 08.09.2020 with unique ISIN - AU0000102683. Main exchange is Australian S.E. and ticker symbol is HLTH. The total expense ratio is 0.45%. The VanEck Vectors Global Healthcare Leaders ETF pays dividends 1 time(s) per year.

结构 HLTH 在 2026-07-13

下载结构至 Excel 文档
证券 值
Illumina Inc 3,11%
West Pharmaceutical Services Inc 2,92%
Arrowhead Pharmaceuticals Inc 2,7%
Exelixis Inc 2,66%
Neurocrine Biosciences Inc 2,65%
Novo Nordisk A/S 2,53%
Ypsomed Holding Ag 2,46%
Incyte Corp 2,45%
Argenx Se 2,43%
Eli Lilly & Co 2,34%
Halozyme Therapeutics Inc 2,32%
Dexcom Inc 2,27%
Alk-Abello A/S 2,24%
Kyowa Kirin Co Ltd 2,17%
Teva Pharmaceutical Industries Ltd 2,17%
Encompass Health Corp 2,13%
Merck & Co Inc 2,08%
Ipsen Sa 2,07%
Johnson & Johnson 2,07%
Vertex Pharmaceuticals Inc 2,01%
Fisher & Paykel Healthcare Corp Ltd 1,99%
United Therapeutics Corp 1,98%
Otsuka Holdings Co Ltd 1,95%
Orion Oyj 1,94%
Amgen Inc 1,93%
Idexx Laboratories Inc 1,91%
Stryker Corp 1,9%
Gsk Plc 1,9%
Bristol-Myers Squibb Co 1,89%
Daiichi Sankyo Co Ltd 1,85%
Alnylam Pharmaceuticals Inc 1,85%
Ucb Sa 1,84%
Penumbra Inc 1,84%
Globus Medical Inc 1,79%
Astrazeneca Plc 1,78%
Hoya Corp 1,74%
Astellas Pharma Inc 1,74%
Tenet Healthcare Corp 1,74%
Alteogen Inc 1,73%
Resmed Inc 1,71%
Samsung Biologics Co Ltd 1,69%
Intuitive Surgical Inc 1,67%
Sk Biopharmaceuticals Co Ltd 1,63%
Shionogi & Co Ltd 1,59%
Universal Health Services Inc 1,57%
Ensign Group Inc/The 1,56%
Chugai Pharmaceutical Co Ltd 1,52%
Insulet Corp 1,42%
Zoetis Inc 1,27%
Boston Scientific Corp 1,26%
Other/Cash 0,05%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权